Getein Biotech, Inc (603387.SS)
CNY 8.59
(-0.12%)
CNY 8.59
(-0.12%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 426.88 Million CNY | -36.91% |
| 2022 | 654.55 Million CNY | 33.28% |
| 2021 | 522.11 Million CNY | 30.03% |
| 2020 | 424.74 Million CNY | -6.11% |
| 2019 | 431.43 Million CNY | 53.63% |
| 2018 | 276.86 Million CNY | 17.67% |
| 2017 | 246.38 Million CNY | 43.92% |
| 2016 | 164.87 Million CNY | 36.38% |
| 2015 | 120.27 Million CNY | 40.14% |
| 2014 | 87.09 Million CNY | 23.21% |
| 2013 | 70.27 Million CNY | 212.13% |
| 2012 | 22.96 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 67.58 Million CNY | -5.3% |
| 2024 Q1 | 109.01 Million CNY | 53.71% |
| 2024 Q2 | 71.86 Million CNY | -45.43% |
| 2023 FY | - CNY | -36.91% |
| 2023 Q3 | 56.7 Million CNY | -10.12% |
| 2023 Q4 | 81.46 Million CNY | 43.65% |
| 2023 Q1 | 147.57 Million CNY | 200.4% |
| 2023 Q2 | 63.09 Million CNY | -57.25% |
| 2022 Q1 | 263.47 Million CNY | 58.96% |
| 2022 FY | - CNY | 33.28% |
| 2022 Q3 | 168.92 Million CNY | 13.65% |
| 2022 Q2 | 148.63 Million CNY | -43.59% |
| 2022 Q4 | 49.12 Million CNY | -70.92% |
| 2021 Q3 | 105.43 Million CNY | -11.35% |
| 2021 Q2 | 118.92 Million CNY | 38.13% |
| 2021 FY | - CNY | 30.03% |
| 2021 Q1 | 86.09 Million CNY | -21.88% |
| 2021 Q4 | 165.75 Million CNY | 57.21% |
| 2020 Q2 | 62.61 Million CNY | 19.49% |
| 2020 Q4 | 110.21 Million CNY | -22.95% |
| 2020 FY | - CNY | -6.11% |
| 2020 Q1 | 52.4 Million CNY | -68.85% |
| 2020 Q3 | 143.04 Million CNY | 128.45% |
| 2019 Q2 | 99.75 Million CNY | 24.69% |
| 2019 Q4 | 168.21 Million CNY | 207.99% |
| 2019 FY | - CNY | 53.63% |
| 2019 Q3 | 54.61 Million CNY | -45.25% |
| 2019 Q1 | 80 Million CNY | 14.05% |
| 2018 Q1 | 69.75 Million CNY | 6.2% |
| 2018 FY | - CNY | 17.67% |
| 2018 Q4 | 70.14 Million CNY | 38.46% |
| 2018 Q3 | 50.66 Million CNY | -21.66% |
| 2018 Q2 | 64.66 Million CNY | -7.29% |
| 2017 Q1 | 44.09 Million CNY | -8.97% |
| 2017 Q2 | 53.13 Million CNY | 20.5% |
| 2017 Q3 | 54.21 Million CNY | 2.03% |
| 2017 Q4 | 65.68 Million CNY | 21.16% |
| 2017 FY | - CNY | 43.92% |
| 2016 Q3 | 31.64 Million CNY | 156.21% |
| 2016 Q1 | 57.63 Million CNY | 0.0% |
| 2016 Q2 | 12.34 Million CNY | -78.57% |
| 2016 Q4 | 48.44 Million CNY | 53.1% |
| 2016 FY | - CNY | 36.38% |
| 2015 Q1 | 24.94 Million CNY | 0.0% |
| 2015 FY | - CNY | 40.14% |
| 2014 FY | - CNY | 23.21% |
| 2013 FY | - CNY | 212.13% |
| 2012 FY | - CNY | 0.0% |